Clinical Trials
4 trialsNCT06523049 2024-07-26
Vorolanib Plus Sintilimab for Advanced Renal Cell Carcinoma After Failure of Prior Immune Checkpoint Inhibitors Based Combination Therapy
West China Hospital
Phase 2 Not yet recruiting
NCT04387500 2024-04-09
Sintilimab Injection Combined With Inlyta in Fumarate Hydratase- Deficient Renal Cell Carcinoma
West China Hospital
Phase 2 Unknown
NCT04958473 2021-07-12
SAARCC
Tianjin Medical University Second Hospital
Phase 2 Unknown
NCT04146831 2020-05-12
Sintilimab in FH-deficient Renal Cell Carcinoma
West China Hospital
Phase 2 Unknown